Financials Amplitude Surgical

Equities

AMPLI

FR0012789667

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris 09:05:13 26/04/2024 pm IST 5-day change 1st Jan Change
3 EUR 0.00% Intraday chart for Amplitude Surgical -1.96% -9.09%

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 146.7 94.5 73.98 106 135.3 159.3
Enterprise Value (EV) 1 240.7 199.4 181.9 222.2 253.4 228.6
P/E ratio -15.6 x -10.5 x -5.22 x -7.53 x -30.8 x 4.06 x
Yield - - - - - -
Capitalization / Revenue 1.46 x 0.92 x 0.84 x 1.11 x 1.55 x 1.59 x
EV / Revenue 2.4 x 1.94 x 2.06 x 2.33 x 2.89 x 2.28 x
EV / EBITDA 16.6 x 9.98 x 15.7 x 16.9 x 13.1 x 10.5 x
EV / FCF -95 x -28.8 x 13.1 x -138 x -28.9 x 27.1 x
FCF Yield -1.05% -3.47% 7.66% -0.72% -3.46% 3.69%
Price to Book 1.53 x 1.09 x 1.02 x 1.8 x 2.5 x 1.66 x
Nbr of stocks (in thousands) 46,861 47,730 47,730 47,753 47,973 47,988
Reference price 2 3.130 1.980 1.550 2.220 2.820 3.320
Announcement Date 02/11/18 31/10/19 02/11/20 29/10/21 27/10/22 26/10/23
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 100.3 102.6 88.29 95.5 87.56 100.2
EBITDA 1 14.52 19.98 11.57 13.12 19.33 21.8
EBIT 1 2.378 2.398 -5.313 0.715 6.874 10.25
Operating Margin 2.37% 2.34% -6.02% 0.75% 7.85% 10.23%
Earnings before Tax (EBT) 1 -8.368 -7.737 -11.31 -12.81 -1.633 -5.998
Net income 1 -9.446 -8.99 -14.2 -14.1 -4.392 39.25
Net margin -9.41% -8.77% -16.08% -14.76% -5.02% 39.17%
EPS 2 -0.2013 -0.1881 -0.2970 -0.2949 -0.0915 0.8170
Free Cash Flow 1 -2.535 -6.927 13.93 -1.607 -8.772 8.43
FCF margin -2.53% -6.75% 15.78% -1.68% -10.02% 8.41%
FCF Conversion (EBITDA) - - 120.35% - - 38.67%
FCF Conversion (Net income) - - - - - 21.48%
Dividend per Share - - - - - -
Announcement Date 02/11/18 31/10/19 02/11/20 29/10/21 27/10/22 26/10/23
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 94 105 108 116 118 69.3
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 6.473 x 5.252 x 9.328 x 8.854 x 6.11 x 3.177 x
Free Cash Flow 1 -2.53 -6.93 13.9 -1.61 -8.77 8.43
ROE (net income / shareholders' equity) -9.7% -10.4% -18.7% -23% -5.16% -9.12%
ROA (Net income/ Total Assets) 0.55% 0.53% -1.2% 0.16% 1.63% 2.44%
Assets 1 -1,733 -1,704 1,187 -8,586 -270.2 1,609
Book Value Per Share 2 2.040 1.820 1.520 1.230 1.130 2.000
Cash Flow per Share 2 0.6300 0.4100 0.7700 0.6400 0.4400 0.7800
Capex 1 6.84 8.4 5.06 5.14 5.19 11.2
Capex / Sales 6.82% 8.19% 5.73% 5.38% 5.93% 11.15%
Announcement Date 02/11/18 31/10/19 02/11/20 29/10/21 27/10/22 26/10/23
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AMPLI Stock
  4. Financials Amplitude Surgical